| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |